rhinoplasty infection. Other infectious disease
Conditions
Interventions
Intervention 1: The first group received a single dose of 2 grams of Cefazolin (3 grams in individuals weighing over 120 kg) prior to operation (at the induction of anesthesia) and 900 milligrams of C
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients 20 to 70 years old rhinoplasty candidates Not receiving antibiotic treatment before study
Exclusion criteria
Exclusion criteria: Patients who have comorbidities such as diabetes, thyroid disorders, and cardiovascular complications including ischemic heart disease and active hepatitis Failure to comply with the treatment protocol or prematurely discontinuing treatment before complete recovery Patient withdrawal from the study participation Patients who have septal perforation American society of aesthediology score > 3 (patients with diabetes with poor blood sugar control, high blood pressure, COPD, body mass index above 40) Individuals with alcohol dependence Operations that last longer than three hours.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of cellulitis and abscess. Timepoint: 1 day after surgery, 1 week after surgery, 2 weeks after surgery, 1 month after surgery. Method of measurement: Clinical Examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactVahid Aghsaghloo
Rasht University of Medical Sciences
Outcome results
None listed